Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20. (Q40485837)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

Fabrizio Accardi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

Massimo De Filippo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

Nicola Giuliani

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

author name string

B Dalla Palma

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

D Guasco

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

M Pedrazzoni

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

F Costa

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

G Sammarelli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

L Craviotto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

P Omedè

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

F Aversa

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

publication date

30 September 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

30

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

409-416

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26419509 AND SRC:MED&resulttype=core&format=json

25 February 2020

Current and future imaging modalities for multiple myeloma and its precursor states

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Pathogenesis of myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1alpha and MIP-1beta correlates with lytic bone lesions in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

CC-chemokine ligand 20/macrophage inflammatory protein-3α and CC-chemokine receptor 6 are overexpressed in myeloma microenvironment related to osteolytic bone lesions.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Bone lesions in molecular subtypes of multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Serum levels of total-RANKL in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

The cytokine/chemokine pattern in the bone marrow environment of multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow up of multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Relationship between initial clinical presentation and the molecular cytogenetic classification of myeloma.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Myeloma cells and bone marrow osteoblast interactions: role in the development of osteolytic lesions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Advances in the regulation of osteoclasts and osteoclast functions

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Correlation between Th17 cells and tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

The systemic cytokine environment is permanently altered in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS)

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-?B ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1038/LEU.2015.259

21 January 2018

Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow plasma macrophage inflammatory protein protein-1 alpha(MIP-1 alpha) and sclerostin in multiple myeloma: relationship with bone disease and clinical characteristics

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of imaging techniques in the management of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of OPG, RANKL and RANKL/OPG ratio in newly-diagnosed patients with multiple myeloma. Clinical correlations

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Langerhans cell histiocytosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum osteoprotegerin levels in healthy controls and cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical significance of soluble human leukocyte antitgen class-I, ICTP, and RANKL molecules in multiple myeloma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma: a clinical overview.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26419509

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40485837&oldid=2203728679"